Trial reportHuman psychopharmacology2025
A Randomized Placebo-Controlled Clinical Trial Exploring the Short-Term Cognitive and Cerebrovascular Effects of Consuming Peppermint Tea: A Mediation Study.
Trial report in Human psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cognitive-enhancing effects of peppermint have been widely reported. Vasodilation, causing an increase in cerebral blood flow (CBF) in the prefrontal cortex, has been implicated as a possible mediator. We tested this here. A total of N = 25 individuals, all aged over 18 years, were recruited via convenience sampling. A randomized, single blind placebo-controlled, independent groups design was used to assess whether groups (peppermint vs. placebo control) could be differentiated with respect to change in cognition, assessed via a computerized battery, and change in cerebral blood flow, assessed with Near-Infrared-Spectroscopy (NIRS), from pre-post intervention. Groups disparities in both cognitive and cerebrovascular change scores (from pre-post intervention) emerged. Improvements in cognitive performance were better in the peppermint group. Increases in hemodynamic activity, indexed by Oxygenated (Oxy-Hb) and Total hemoglobin (Total-Hb), were also greater in the peppermint group. Cerebrovascular changes from pre-to post-intervention were unrelated to cognitive changes over the same period, ruling out mediation effects. In conclusion, 200 mL of peppermint, consumed as tea, effectively boosted cognition and cerebral blood flow in otherwise healthy adults. Increased cerebral blood flow, however, did not mediate the cognitive-enhancing effects of peppermint. Future research incorporating larger samples and exploring other neurophysiological mediators is encouraged.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.